VRPX — Virpax Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapNeutral

Annual balance sheet for Virpax Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash
Cash and Short Term Investments	0.042	0.055	36.8	19	9.14
Net Total Accounts Receivable
Net Total Receivables	0.001	0	—	—	—
Prepaid Expenses
Total Other Current Assets
Total Current Assets	0.047	0.073	39.6	19.7	9.63
Other Long Term Assets
Total Assets	0.047	0.465	39.6	19.7	9.63
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	2.78	3.66	2.09	3.09	7.69
Long Term Debt
Total Long Term Debt
Total Debt
Total Liabilities	2.78	4.68	2.09	3.09	7.69
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	-2.73	-4.22	37.5	16.6	1.93
Total Liabilities & Shareholders' Equity	0.047	0.465	39.6	19.7	9.63
Total Common Shares Outstanding